These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 24987921)
21. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment. Kasamatsu T; Okada S; Tsuda H; Shiromizu K; Yamada T; Tsunematsu R; Ohmi K Gynecol Oncol; 2002 May; 85(2):327-32. PubMed ID: 11972396 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix. Utsugi K; Shimizu Y; Akiyama F; Umezawa S; Hasumi K Gynecol Oncol; 2004 Jan; 92(1):64-70. PubMed ID: 14751140 [TBL] [Abstract][Full Text] [Related]
23. Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge. Korach J; Machtinger R; Perri T; Vicus D; Segal J; Fridman E; Ben-Baruch G Acta Obstet Gynecol Scand; 2009; 88(3):355-8. PubMed ID: 19172445 [TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB. Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760 [TBL] [Abstract][Full Text] [Related]
26. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863 [TBL] [Abstract][Full Text] [Related]
27. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study. Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194 [TBL] [Abstract][Full Text] [Related]
28. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?]. Reed W; Abeler VM; Tropé CG Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177 [TBL] [Abstract][Full Text] [Related]
29. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma. Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757 [TBL] [Abstract][Full Text] [Related]
30. Villoglandular adenocarcinoma of cervix--a tumour with bland cytological features: report of a case missed on cytology. Jayaram G; Razak A Malays J Pathol; 2003 Dec; 25(2):139-43. PubMed ID: 16196371 [TBL] [Abstract][Full Text] [Related]
31. The role of high risk HPV lymph node positivity in the surgical staging of cancer of the uterine cervix. Sápy T; Hernádi Z; Lukácskó L; Borsos A Acta Chir Hung; 1997; 36(1-4):313-5. PubMed ID: 9408386 [TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix. Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701 [TBL] [Abstract][Full Text] [Related]
33. PD-L1 Expression and Silva Invasion Pattern in Villoglandular Adenocarcinoma of the Uterine Cervix. Dietl AK; Beckmann MW; Stuebs FA; Gass P; Emons J; Hartmann A; Erber R Int J Gynecol Pathol; 2024 Jul; 43(4):397-404. PubMed ID: 38293999 [TBL] [Abstract][Full Text] [Related]
34. Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors. Li P; Ma J; Zhang X; Guo Y; Liu Y; Li X; Zhao D; Wang Z Diagn Pathol; 2018 May; 13(1):31. PubMed ID: 29788963 [TBL] [Abstract][Full Text] [Related]
35. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix. Tong SY; Lee YS; Park JS; Namkoong SE Int J Gynecol Cancer; 2007; 17(6):1307-13. PubMed ID: 17425678 [TBL] [Abstract][Full Text] [Related]
37. [Primary clear cell carcinoma of the cervix: report of five cases and review of the literature]. Tan YT; Zhang X; Lin ZQ; Chen Q; Wang LJ; Zhang BZ Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):120-3. PubMed ID: 18683751 [TBL] [Abstract][Full Text] [Related]
38. The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix. Kim JH; Park JY; Kim DY; Kim YM; Kim YT; Nam JH Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):100-3. PubMed ID: 19428171 [TBL] [Abstract][Full Text] [Related]
39. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis. Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009 [TBL] [Abstract][Full Text] [Related]
40. HPV infection and p16 Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]